Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 1/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | ERN1 | O75460 | 7/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15814101 | 0.93 | PRKDC (0.72) | PRKDCLMNAALDH1A1HPGDMAPT | |
| SCHEMBL21822870 | 0.85 | PRKDC (0.61) | PRKDCLMNAALDH1A1HPGDMAPT | |
| SCHEMBL515642 | 0.84 | PRKDC (1.00) | PRKDCLMNAALDH1A1HPGDMAPT | |
| SCHEMBL15054285 | 0.82 | ALDH1A1 (0.55) | PRKDCLMNAALDH1A1HPGDMAPT | |
| SCHEMBL7401545 | 0.82 | ALDH1A1 (0.69) | PRKDCLMNAALDH1A1HPGDMAPT | |
| SCHEMBL30665931 | 0.82 | PRKDC (0.81) | PRKDCLMNAALDH1A1HPGDMAPT | |
| SCHEMBL18270047 | 0.82 | PRKDC (0.81) | PRKDCLMNAALDH1A1HPGDMAPT | |
| SCHEMBL14581264 | 0.79 | PRKDC (0.75) | PRKDCLMNAALDH1A1HPGDMAPT | |
| SCHEMBL16411776 | 0.79 | PRKDC (0.75) | PRKDCLMNAALDH1A1HPGDMAPT | |
| SCHEMBL10394357 | 0.79 | ALDH1A1 (0.69) | PRKDCLMNAALDH1A1HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025036241-A1 | COMPOUNDS AND METHODS FOR MODULATING RNA SPLICING | RIBOPEUTIC INC. (CN) | 2025-02-20 | — | — | WO | disclosed |
| US-11834466-B2 | Benzoxaborole compounds and formulations thereof | 5METIS, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| US-11834466-B2 | Benzoxaborole compounds and formulations thereof | 5METIS, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| US-20200385409-A1 | BENZOXABOROLE COMPOUNDS AND FORMULATIONS THEREOF | Boragen, Inc. | 2020-12-10 | — | — | US | disclosed |
| EP-3716766-A1 | BENZOXABOROLE COMPOUNDS AND FORMULATIONS THEREOF | Boragen, Inc. (US) | 2020-10-07 | — | — | EP | disclosed |
| CN-111655035-A | Benzoxaborole compounds and formulations thereof | 博瑞金股份有限公司 | 2020-09-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200385409-A1 | BENZOXABOROLE COMPOUNDS AND FORMULATIONS THEREOF | SSB, NONO, LRBA | PRKDC 4839/4885LMNA 538/4885ALDH1A1 4598/4885 |
| US-11834466-B2 | Benzoxaborole compounds and formulations thereof | SSB, NONO, LRBA | PRKDC 4839/4885LMNA 538/4885ALDH1A1 4598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.